Northwire Canada EditionTuesday, October 20, 2026
Northwire
⌕
GOLD 4133.20 −0.7% SILVER 57.09 −0.3% COPPER 6.57 −0.0% OIL 100.02 +1.5% PALLADIUM 1100.25 −2.0% KC 0.400 +0.0% FUU 0.120 +4.3% ECR 0.250 −3.9% MLP 2.23 +10.9% MTT 0.240 −4.0% RRI 0.365 +1.4% APMI 0.110 −4.3% ALTN 0.080 −5.9% OSM 0.025 +0.0% ALS 55.40 −2.0% BGD 0.080 +14.3% LVG 0.350 +2.9% PER 0.110 +0.0% KCC 0.880 −7.4% ARG 7.93 −2.7% NRN 0.040 −11.1% GOLD 4133.20 −0.7% SILVER 57.09 −0.3% COPPER 6.57 −0.0% OIL 100.02 +1.5% PALLADIUM 1100.25 −2.0% KC 0.400 +0.0% FUU 0.120 +4.3% ECR 0.250 −3.9% MLP 2.23 +10.9% MTT 0.240 −4.0% RRI 0.365 +1.4% APMI 0.110 −4.3% ALTN 0.080 −5.9% OSM 0.025 +0.0% ALS 55.40 −2.0% BGD 0.080 +14.3% LVG 0.350 +2.9% PER 0.110 +0.0% KCC 0.880 −7.4% ARG 7.93 −2.7% NRN 0.040 −11.1%
M&A / Property

Abaxx Technologies Acquires Strategic Position in ARTEX AG, Extending Capabilities in Europe and to New Markets in Fine Art

ABXX · Price

Executive Summary

  • Abaxx Technologies Inc. announced the acquisition of a strategic position in ARTEX AG through two tranches of zero‑coupon convertible debentures and accompanying share purchase warrants.
  • The cooperation agreement gives Abaxx access to ARTEX’s regulated fine‑art trading platform, enabling development of futures contracts on Abaxx Exchange backed by a transparent art price index.
  • First tranche of Artex Debentures has been issued; the second tranche is expected to close around January 2026.

Key Details

  • Investment Structure:
  • Two tranches of zero‑coupon convertible debentures (“Artex Debentures”).
  • Each debenture convertible into up to 10% of ARTEX’s fully diluted common shares at a deemed conversion price of US$1,000,000 per ~1% share.
  • Conversion right exercisable for three years from each debenture’s issuance date.

  • Warrant Component:

  • Common share purchase warrants (“Artex Warrants”) granting Abaxx the right to acquire an additional up to 9.9% of ARTEX’s fully diluted common shares.
  • Warrants exercisable for three years from issuance; exercise price based on ARTEX valuation at time of exercise, subject to board and regulatory approval.

  • Tranche Timing:

  • First tranche of debentures already issued.
  • Second tranche expected to close on or around January 2026.

  • Strategic Benefits for Abaxx:

  • Access to a new regulated European market for Abaxx’s Digital Title and ID++ technology.
  • Source of real‑time transaction data to build a fine‑art price index, underpinning future benchmark futures contracts on Abaxx Exchange.
  • Partnership with ARTEX’s network of institutional partners (European banks, asset managers, etc.).

  • Strategic Benefits for ARTEX:

  • Integration of Abaxx’s market‑structure expertise and digital title technology to enhance liquidity and robustness of the fine‑art trading venue.

  • Quotes:

  • “Smarter markets require smarter data and trusted market infrastructure… By integrating our platforms, we expand our technology footprint into a global asset class and secure the foundation for a pipeline of new, tradable futures products on Abaxx Exchange.” – Josh Crumb, Founder & CEO, Abaxx Technologies.
  • “Abaxx is the ideal partner to accelerate our mission… Together, we will enhance robustness, expand global reach and provide critical validation to our institutional partners as we establish art as a legitimate mainstream asset class.” – Yassir Benjelloun‑Touimi, CEO & Co‑Founder, ARTEX.

Notable Quotes

  • See above under Quotes.
Read the original news release →

More from ABAXX TECHNOLOGIES INC.